Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (761-770 of 903) with videos related to

Pageof 91
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2020
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancerYing L Liu, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|May 15, 2026
Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyLindsey Finch, Christian Dagher, Christina Harlev, et al.
Bone Marrow Transplantation|October 2, 2003
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical courseK-H Lee, J-H Lee, S-J Choi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatomaS J Wang, W Y Lin, M N Chen, et al.
Cancer Research|June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated CytotoxicityKensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Bone Marrow Transplantation|January 18, 2005
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSFJ-L Lee, S Kim, S W Kim, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 20, 2012
Fetal brain mTOR signaling activation in tuberous sclerosis complexVictoria Tsai, Whitney E Parker, Ksenia A Orlova, et al.
Gynecologic Oncology|July 9, 2010
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomasDennis S Chi, Oliver Zivanovic, Kimberly L Levinson, et al.
AJR. American Journal of Roentgenology|July 12, 2023
Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician SatisfactionPamela Causa Andrieu, Ines Nikolovski, Krishna Juluru, et al.
Gynecologic Oncology|October 24, 2025
Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?Sarah Andres, Andrew Tannous, Ryan M Kahn, et al.
Pageof 91

Showing results (761-770 of 903) with videos related to

Sort By:
Pageof 91
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2020
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancerYing L Liu, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|May 15, 2026
Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyLindsey Finch, Christian Dagher, Christina Harlev, et al.
Bone Marrow Transplantation|October 2, 2003
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical courseK-H Lee, J-H Lee, S-J Choi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatomaS J Wang, W Y Lin, M N Chen, et al.
Cancer Research|June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated CytotoxicityKensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Bone Marrow Transplantation|January 18, 2005
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSFJ-L Lee, S Kim, S W Kim, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 20, 2012
Fetal brain mTOR signaling activation in tuberous sclerosis complexVictoria Tsai, Whitney E Parker, Ksenia A Orlova, et al.
Gynecologic Oncology|July 9, 2010
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomasDennis S Chi, Oliver Zivanovic, Kimberly L Levinson, et al.
AJR. American Journal of Roentgenology|July 12, 2023
Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician SatisfactionPamela Causa Andrieu, Ines Nikolovski, Krishna Juluru, et al.
Gynecologic Oncology|October 24, 2025
Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?Sarah Andres, Andrew Tannous, Ryan M Kahn, et al.
Pageof 91